Wolff Wiese Magana’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $563 | Hold |
60
| – | – | ﹤0.01% | 898 |
|
|
2025
Q1 | $427 | Hold |
60
| – | – | ﹤0.01% | 930 |
|
|
2024
Q4 | $700 | Sell |
60
-70
| -54% | -$817 | ﹤0.01% | 853 |
|
|
2024
Q3 | $2.67K | Hold |
130
| – | – | ﹤0.01% | 688 |
|
|
2024
Q2 | $2.91K | Hold |
130
| – | – | ﹤0.01% | 498 |
|
|
2024
Q1 | $3.58K | Hold |
130
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $3.96K | Sell |
130
-30
| -19% | -$915 | ﹤0.01% | 406 |
|
|
2023
Q3 | $5.06K | Sell |
160
-100
| -38% | -$3.16K | ﹤0.01% | 432 |
|
|
2023
Q2 | $10.6K | Hold |
260
| – | – | 0.01% | 339 |
|
|
2023
Q1 | $9.69K | Sell |
260
-70
| -21% | -$2.61K | 0.01% | 353 |
|
|
2022
Q4 | $11.5K | Sell |
330
-55
| -14% | -$1.92K | 0.01% | 321 |
|
|
2022
Q3 | $22K | Hold |
385
| – | – | 0.02% | 360 |
|
|
2022
Q2 | $20K | Sell |
385
-8
| -2% | -$416 | 0.01% | 399 |
|
|
2022
Q1 | $29K | Sell |
393
-993
| -72% | -$73.3K | 0.02% | 353 |
|
|
2021
Q4 | $164K | Sell |
1,386
-78
| -5% | -$9.23K | 0.11% | 147 |
|
|
2021
Q3 | $196K | Buy |
1,464
+259
| +21% | +$34.7K | 0.14% | 129 |
|
|
2021
Q2 | $195K | Buy |
+1,205
| New | +$195K | 0.14% | 126 |
|